XML 18 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Operating activities    
Net income (loss) from continuing operations $ 30,670 $ (29,811)
Net income (loss) from discontinued operations 3,438 (37,909)
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation and amortization 4,538 4,783
Provision for loan and lease losses 2,150 1,810
Net amortization of investment securities discounts/premiums 6,955 6,066
Stock-based compensation expense 2,400 1,990
Loans originated for sale (398,410) (372,065)
Sale of loans originated for resale 453,976 299,855
Gain on sales of loans originated for resale (13,119) (809)
Loss (gain) on sale of fixed assets 28 (21)
Loss on sale of other real estate owned 19  
Fair value adjustment on investment in unconsolidated entity (20) 14,753
Gain on sales of investment securities (1,595) (3,131)
Decrease (increase) in accrued interest receivable 458 (1,025)
Decrease (increase) in other assets 872 (19,290)
Decrease (increase) in discontinued assets held for sale 1,123 (5,779)
Increase (decrease) in other liabilities (18,794) 10,505
Net cash provided by (used in) operating activities 74,689 (130,078)
Investing activities    
Purchase of investment securities available-for-sale (237,870) (499,969)
Proceeds from sale of investment securities available-for-sale 83,918 115,637
Proceeds from redemptions and prepayments of securities held-to-maturity 7,000 51
Proceeds from redemptions and prepayments of securities available-for-sale 234,163 133,212
Proceeds from sale of other real estate owned 85  
Net increase in loans (152,484) (120,312)
Net decrease in discontinued loans held for sale 44,594 203,533
Proceeds from sale of fixed assets 366 341
Purchases of premises and equipment (625) (4,237)
Investment in unconsolidated entity 19,239 6,371
Net cash used in investing activities (1,614) (165,373)
Financing activities    
Net decrease in deposits (672,909) (647,822)
Net decrease in securities sold under agreements to repurchase (94) (572)
Proceeds of short-term borrowings and federal funds purchased   70,000
Common stock issuance expense (200)  
Proceeds from the issuance of common stock   74,812
Net cash used in financing activities (673,203) (503,582)
Net decrease in cash and cash equivalents (600,128) (799,033)
Cash and cash equivalents, beginning of period 999,059 1,155,162
Cash and cash equivalents, end of period 398,931 356,129
Supplemental disclosure:    
Interest paid 11,176 9,514
Taxes paid $ 1,051 $ 366